Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Matthew Madin-Warburton"'
Autor:
Marieke Schurer, Renu Patel, Marjolijn van Keep, Jake Horgan, Suzette Matthijsse, Matthew Madin-Warburton
Publikováno v:
Frontiers in Medical Technology, Vol 5 (2023)
BackgroundAntimicrobial resistance (AMR) is a growing threat to global health. With pathogenic bacteria inevitably becoming more resistant to existing antimicrobials, mortality and costs due to AMR will significantly increase over the next few decade
Externí odkaz:
https://doaj.org/article/32ba833db15e4b7b9213ef9ca90c8300
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Clostridioides difficile is a Gram-positive anaerobic bacterium, which causes Clostridioides difficile infection (CDI). It has been recognised as a leading cause of healthcare-associated infections and a considerable threat to pub
Externí odkaz:
https://doaj.org/article/cf89b4c99fa74178a0d4e30735b74cd2
Autor:
Christopher Fitzpatrick, Fiona M Fleming, Matthew Madin-Warburton, Timm Schneider, Filip Meheus, Kingsley Asiedu, Anthony W Solomon, Antonio Montresor, Gautam Biswas
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 10, Iss 12, p e0005037 (2016)
Advocacy around mass treatment for the elimination of selected Neglected Tropical Diseases (NTDs) has typically put the cost per person treated at less than US$ 0.50. Whilst useful for advocacy, the focus on a single number misrepresents the complexi
Externí odkaz:
https://doaj.org/article/0ba6ab6044f34ce9baedf96c978c5615
Autor:
K. Ray Chaudhuri, A. Simon Pickard, Ali Alobaidi, Yash J. Jalundhwala, Prasanna L. Kandukuri, Yanjun Bao, Julia Sus, Glynn Jones, Christian Ridley, Julia Oddsdottir, Seyavash Najle-Rahim, Matthew Madin-Warburton, Weiwei Xu, Anette Schrag
Publikováno v:
PharmacoEconomics. 40(5)
Parkinson's disease is a progressive neurodegenerative disease, which significantly impacts patients' quality of life and is associated with high treatment and direct healthcare costs. In England, levodopa/carbidopa intestinal gel (LCIG) is indicated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07771681a314bcf4d8627f1f0cf48fae
https://pubmed.ncbi.nlm.nih.gov/35307793
https://pubmed.ncbi.nlm.nih.gov/35307793
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
Background Clostridioides difficile is a Gram-positive anaerobic bacterium, which causes Clostridioides difficile infection (CDI). It has been recognised as a leading cause of healthcare-associated infections and a considerable threat to public healt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a4bfd7f987e9eee8b3475bc094bc481
https://pubmed.ncbi.nlm.nih.gov/34016040
https://pubmed.ncbi.nlm.nih.gov/34016040
Aims: Dulaglutide is a new once weekly glucagon-like peptide-1 (GLP-1) receptor agonist administered via a disposable auto-injection pen for the management of type 2 diabetes mellitus (T2DM). The objective of this study was to estimate the cost-effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::185af038ad3194e4891df002f9398692
Autor:
Jane Chang, Christopher Ngai, Ashley B. Pitcher, Katja Draexler, David Tamoschus, Matthew Madin-Warburton
Publikováno v:
Clinical drug investigation. 37(6)
No study has compared the cost-effectiveness of active treatment options for unresectable or metastatic gastrointestinal stromal tumours in patients who progressed on or are intolerant to prior treatment with imatinib and sunitinib. The aim of this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ebb0e0f1fcaf70311cb5aa84228a9a4
https://pubmed.ncbi.nlm.nih.gov/28361439
https://pubmed.ncbi.nlm.nih.gov/28361439
Autor:
Matthew Madin-Warburton, Kingsley Asiedu, Timm Schneider, Filip Meheus, Antonio Montresor, Christopher Fitzpatrick, Gautam Biswas, Fiona M. Fleming, Anthony W. Solomon
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 10, Iss 12, p e0005037 (2016)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Background Advocacy around mass treatment for the elimination of selected Neglected Tropical Diseases (NTDs) has typically put the cost per person treated at less than US$ 0.50. Whilst useful for advocacy, the focus on a single number misrepresents t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94ebe1f9965db08b67deef36c9e0cba1
http://europepmc.org/articles/PMC5137870?pdf=render
http://europepmc.org/articles/PMC5137870?pdf=render
Publikováno v:
Open Forum Infectious Diseases
Background Routine use of pneumococcal conjugate vaccines (PCVs) in young children has substantially reduced vaccine-type invasive pneumococcal disease (IPD) in the United States and Europe. However, increases in disease and colonization caused by no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05ec8c40028ad055bd98cebdc7048ab5
http://europepmc.org/articles/PMC6253574
http://europepmc.org/articles/PMC6253574
Autor:
Chaudhuri, K. Ray, Azulay, Jean-Philippe, Odin, Per, Lindvall, Susanna, Domingos, Josefa, Alobaidi, Ali, Kandukuri, Prasanna L., Chaudhari, Vivek S., Parra, Juan Carlos, Yamazaki, Toru, Oddsdottir, Julia, Wright, Jack, Martinez-Martin, Pablo
Publikováno v:
Drugs - Real World Outcomes; Mar2024, Vol. 11 Issue 1, p1-11, 11p